Is Cotinga Pharmaceuticals Inc. (COTQF) a Buy, Sell, or Hold?
OTC : COTQF
Cotinga Pharmaceuticals Inc.
$0.0001 USD
$0 (0.0%)
- Volume
- 0
- Average Volume
- 3.97K
- Market Capitalization
- $2.2K
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.00
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.14
Company Overview
OTC
Richard T. Ho
Biotechnology
Healthcare
COTQF
N/A
CA
USD
Liquidity Metrics
-0.08
0.14
0.14
0.06
0.00
Sales & Valuation
-$
0.00
0.00
0.00
-0.06
Profitability
-$0.0913
-$2.01M
0.00%
0.00%
132.92%
-216.08%
P/E Metrics
0.00
0.00
0.00
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
-9799.14
2/9
-$3463.42
$687.38
$3636.63
-$2.03M
Key Metrics (TTM)
-$16119.0
0.00
0.01
0.14
132.92%
122.61%
-91318.30%
-57631.25%
0 days
Company Executives
| Name | Title |
|---|---|
| Paul Papi | Vice President of Investor Relations |
| Richard T. | Chief Scientific Officer |
| Victor Hugo | Chief Financial Officer |
Poll Results
No votes yet today — be the first to share your view!
About Cotinga Pharmaceuticals Inc. (OTC:COTQF) Stock
Cotinga Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm focused on developing innovative treatments for cancer and other medical conditions currently lacking adequate solutions. Its leading therapeutic asset is COTI-2, an oral small molecule formulated to target the p53 tumor suppressor gene. The company is also progressing COTI-219, another oral small molecule compound, specifically engineered to inhibit mutant forms of KRAS without affecting the normal functions of the KRAS gene. In collaboration with St. Vincent's University Hospital, Cotinga is conducting research to evaluate COTI-2 when combined with eribulin for patients suffering from triple-negative metastatic breast cancer. The company, which was previously known as Critical Outcome Technologies Inc., rebranded to ... Cotinga Pharmaceuticals Inc. in January 2018. Its corporate base is situated in Toronto, Canada.
Frequently Asked Questions
-
What is the current Cotinga Pharmaceuticals Inc. (COTQF) stock price?
-
Cotinga Pharmaceuticals Inc.(OTC:COTQF) stock price is $0.0001 in the last trading session. During the trading session, COTQF stock reached the peak price of $0.0001 while $0.0001 was the lowest point it dropped to. The percentage change in COTQF stock occurred in the recent session was 0.0% while the dollar amount for the price change in COTQF stock was $0.
-
COTQF's industry and sector of operation?
-
The OTC listed COTQF is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of COTQF?
-
Paul Papi | Vice President of Investor Relations
Richard T. | Chief Scientific Officer
Victor Hugo | Chief Financial Officer
|
| -
How many employees does COTQF have?
-
Number of COTQF employees currently stands at None. COTQF operates from The Canadian Venture Building, Toronto, ON M5C 1P1, CA.
-
Link for COTQF official website?
-
Official Website of COTQF is: https://www.cotingapharma.com
-
How do I contact COTQF?
-
COTQF could be contacted at phone #None and can also be accessed through its website. COTQF operates from The Canadian Venture Building, Toronto, ON M5C 1P1, CA.
-
How many shares of COTQF are traded daily?
-
The average number of COTQF shares traded daily for last 3 months was 3.97K.
-
What is the market cap of COTQF currently?
-
The market value of COTQF currently stands at $2.2K with its latest stock price at $0.0001